Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Daptomycin (cubicin) - Important safety information from Novartis as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
31/01/2011
Problem Or Issue:
Important safety information communication from Novartis on the association of daptomycin (cubicin) with eosinophilic pneumonia.
Important safety information - Daptomycin (cubicin)
« Back
Date Printed: 04/05/2024